Doxycycline shows promise in reducing deaths and seizures from nodding syndrome

FHS
June 8, 2024
11:47 am

A new study suggests that a course of the drug doxycycline can decrease acute seizure-related hospitalization and deaths related to nodding syndrome.

40 doesn’t look good on Hatch-Waxman

As the Hatch-Waxman Act approaches its 40th anniversary, it’s time to critically examine its legacy and what it actually gave us: the highest drug prices in

September 23, 2024

Verano Reports 3% Sequential Revenue Growth in Q2 to $234.1 Million

Verano Announces Second Quarter 2023 Financial Results Company Delivers Record Quarterly Revenue of $234 Million and Tightens 2023 Free Cash Flow¹ Guidance to $65-75 Million

August 8, 2023

Aspirin may lower colorectal cancer risk for people with unhealthy lifestyles

Regular aspirin may help lower risk of colorectal cancer in people with greater lifestyle-related risk factors for the disease, according to a study led by

August 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.